No Cafe I’m not. Cash burn is an issue for a lot of bio companies on the ASX. But not many have at least a product they can sell. Oncosil is one of a very few that has that ability. Sure, it has been frustrating and slow but at least it has a CE approval and is in use and being sold. Plenty of bio companies with zero sales, and costly cash burning trials.
Rights Issue, page-22
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.99M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2600000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 405910 | 1 |
View Market Depth
| Last trade - 09.39am 28/06/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable